medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2024, Number 4

<< Back Next >>

Acta Ortop Mex 2024; 38 (4)

Avascular necrosis of the femoral head after COVID-19: clinical presentation and management. Clinical-functional outcomes of decompression and supplementation with bone marrow cell aspirate

Godoy-Monzón D, Cid-Casteulani A, Svarzchtein S, Sasaki S, Pascual-Espinosa J

Language: Spanish
References: 24
Page: 208-213
PDF size: 291.49 Kb.


ABSTRACT

Introduction: the pandemic of COVID-19 has led to clinical complications such as avascular necrosis of the femoral head (AVNFH) associated with the use of corticosteroids. The aim of the study is to report the functional and radiographic results of 13 patients with post-COVID-19 ANFH after decompression using Forage and bone marrow aspirate concentrate (BMAC). Material and methods: single-center, prospective, uncontrolled clinical study. From April 2020 to September 2021, 13 patients (21 hips) with post-COVID-19 ANFH were treated. All received corticosteroids during infection (average daily dose: 480 mg). Clinical, radiographic and magnetic resonance imaging evaluations were performed; the Ficat classification was applied for the classification of AVNFH. The surgical technique used was decompression with Forage and ACMO. Results: the mean age was 47 years, with a follow-up of 30.4 months. Symptoms appeared with a mean of 4.2 months after COVID-19 infection. Harris score improved from 41.2 ± 5.2 to 86.6 ± 3.4. Radiographic evaluation showed that 14.3% of the sample experienced femoral head collapse and underwent total hip arthroplasty. Conclusions: post-COVID-19 ANFH is a clinical entity with rapid progression and different degrees of severity. Decompression with Forage and ACMO seems a promising initial treatment, however, the variable response and the probability of collapse emphasize the importance of long-term follow-up and identification of patients who may require additional interventions.


REFERENCES

  1. Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect. 2020; 9(1): 2190-9. doi: 10.1080/22221751.2020.1825914.

  2. Powell C, Chang C, Naguwa SM, Cheema G, Gershwin ME. Steroid induced osteonecrosis: An analysis of steroid dosing risk. Autoimmun Rev. 2010; 9(11): 721-43. doi: 10.1016/j.autrev.2010.06.007.

  3. Jones JP. Osteonecrosis. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. pp. 2143-64.

  4. Callejas Rubio JL, Luna Del Castillo JD, de la Hera Fernández J, Guirao Arrabal E, Colmenero Ruiz M, Ortego Centeno N. Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection. Med Clin (Engl Ed). 2020; 155(4): 159-61.

  5. RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021; 384(8): 693-704.

  6. Yamamoto T, Schneider R, Iwamoto Y, Bullough PG. Rapid destruction of the femoral head after a single intraarticular injection of corticosteroid into the hip joint. J Rheumatol. 2006; 33(8): 1701-4. Erratum in: J Rheumatol. 2006; 33(10): 2101.

  7. Rajput S, Kulshreshtha B. Bilateral femoral head avascular necrosis with physiological doses of steroids. Indian J Endocrinol Metab. 2018; 22(5): 710-1.

  8. Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br. 1985; 67(1): 3-9.

  9. Lara-Taranchenko Y, Pujol O, González-Morgado D, Hernández A, Barro V, Soza D. Validation of the Spanish version of the modified Harris score. Rev Esp Cir Ortop Traumatol. 2024; 68(2): 121-7. doi: 10.1016/j.recot.2023.03.013.

  10. Roles NC, Maudsley RH. Radial tunnel syndrome: resistant tennis elbow as a nerve entrapment. J Bone Joint Surg Br. 1972; 54(3): 499-508.

  11. Coronavirus disease (COVID-19) pandemic. Geneva: World Health organization; 2021. Available in: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

  12. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27(4): 601-15.

  13. Sugano N, Atsumi T, Ohzono K, Kubo T, Hotokebuchi T, Takaoka K. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci. 2002; 7(5): 601-5. doi: 10.1007/s007760200108.

  14. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002; (405): 14-23. doi: 10.1097/00003086-200212000-00003.

  15. Hungerford DS, Zizic TM. Alcoholism associated ischemic necrosis of the femoral head. Early diagnosis and treatment. Clin Orthop Relat Res. 1978; (130): 144-53.

  16. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am. 2006; 88(5): 1117-32. doi: 10.2106/JBJS.E.01041. Erratum in: J Bone Joint Surg Am. 2006; 88(7): 1602.

  17. Cohen-Rosenblum A, Quanjun C. Osteonecrosis of the femoral head. Orthop Clin North Am. 2019; 50(2): 139-49.

  18. Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res. 1996; (324): 169-78. doi: 10.1097/00003086-199603000-00020.

  19. Song WS, Yoo JJ, Kim YM, Kim HJ. Results of multiple drilling compared with those of conventional methods of core decompression. Clin Orthop Relat Res. 2007; 454: 139-46. doi: 10.1097/01.blo.0000229342.96103.73.

  20. Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011; 49(5): 1005-9. doi: 10.1016/j.bone.2011.07.032.

  21. Ma Y, Wang T, Liao J, Gu H, Lin X, Jiang Q, et al. Efficacy of autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of femoral head: a prospective, double-blinded, randomized, controlled study. Stem Cell Res Ther. 2014; 5(5): 115.

  22. Hernigou P, Dubory A, Homma Y, Guissou I, Flouzat Lachaniette CH, Chevallier N, et al. Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop. 2018; 42(7): 1639-49. doi: 10.1007/s00264-018-3941-8.

  23. Li M, Ma Y, Fu G, Zhang R, Li Q, Deng Z, et al. 10-year follow-up results of the prospective, double-blinded, randomized, controlled study on autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of the femoral head. Stem Cell Res Ther. 2020; 11(1): 287.

  24. Li M, Chen D, Ma Y, Zheng M, Zheng Q. Stem cell therapy combined with core decompression versus core decompression alone in the treatment of avascular necrosis of the femoral head: a systematic review and meta-analysis. J Orthop Surg Res. 2023; 18(1): 560. doi: 10.1186/s13018-023-04025-8.



EVIDENCE LEVEL

II




2020     |     www.medigraphic.com